Recent MIRA News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 08:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 11:00:15 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 09:20:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/27/2024 08:45:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 08:01:33 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 09/06/2024 08:38:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 12:20:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2024 08:05:09 PM
- IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts • IH Market News • 08/26/2024 12:58:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:15:12 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/16/2024 08:05:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:29 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/12/2024 12:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:13:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:54:37 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/26/2024 08:55:26 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/26/2024 08:49:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 08:07:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:12:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:00:40 PM
- MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical Testing • PR Newswire (US) • 06/24/2024 12:30:00 PM
- Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year • PR Newswire (US) • 06/10/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:00:06 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM